Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CAMBREX CORPORATION

(CBM)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cambrex Expands Analytical Services Capabilities at Longmont, Colorado, Facility

05/05/2021 | 08:00am EDT

Cambrex announced an expansion of cGMP analytical testing capabilities at its site in Longmont, Colorado. Existing space at the site has been repurposed with cutting edge technologies and doubles the footprint of the laboratory operations. The world-class facility will gain approximately 1,800ft2 of laboratory space with a lean continuous improvement design deployed across the open module layout for efficiency. The expansion includes the addition of chromatographic equipment including uHPLC, HPLC, GC-FID/HS, and dissolution equipment (Apparatus 1 and 2 with online UV/Vis), as well as additional laboratory support equipment including 10 chemical fume hoods and working bench space. The Longmont facility became part of the Cambrex global network of development and manufacturing facilities following the acquisition of Avista Pharma Solutions in 2019. The site supports customers with the development and manufacture of small molecule drug substance and drug product and provides full analytical development and cGMP testing support from discovery through to clinical scale. The site is fully integrated with direct technical transfer lines for commercial scale advancement to the Charles City, Mirabel, and Whippany sites.


© S&P Capital IQ 2021
All news about CAMBREX CORPORATION
10/07Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence At High Poin..
CI
06/23Omega Therapeutics Expands Board of Directors with Appointment of Luke Beshar
CI
05/26Cambrex Introduces New Kilogram-Scale Gmp Manufacturing Capabilities At Tallinn, Estoni..
CI
05/05Cambrex Expands Analytical Services Capabilities at Longmont, Colorado, Facility
CI
2020Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabili..
CI
2020Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
CI
2020Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
CI
2020Cambrex Appoints Thomas Loewald as Member of the Board of Directors Effective September..
CI
2020Cambrex Appoints Thomas Loewald as Chief Executive Officer Effective September 7, 2020
CI
2020Cambrex Announces Board Changes
CI
More news
Managers and Directors
Thomas W. Loewald Chief Executive Officer & Director
Wayne M. Hewett Chairman
Claes Johan Robert Glassell Director
Henry Minello Director
Laura O'Donnell Director
Sector and Competitors
1st jan.Capi. (M$)
CAMBREX CORPORATION0.00%2 023
JOHNSON & JOHNSON4.07%431 148
ROCHE HOLDING AG13.98%333 101
PFIZER, INC.14.34%239 966
NOVO NORDISK A/S56.26%238 738
ELI LILLY AND COMPANY44.35%220 952